Tirzepatide associated with better outcomes for diabetes than Semaglutide

29 Sep 2023

A study presented at the European Association for the Study of Diabetes Annual Meeting has found that the weight loss drug Tirzepatide is more effective than Semaglutide in improving HbA1c and reducing weight in patients with type 2 diabetes.


Related Topics

Diabetes Obesity

Share this story